Puma Biotechnology Inc (PBYI) financial statements (2021 and earlier)

Company profile

Business Address 10880 WILSHIRE BLVD.
LOS ANGELES, CA 90024
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:9311216582229216141
Cash and cash equivalents8560108821943239
Short-term investments85257 35184103
Other undisclosed cash, cash equivalents, and short-term investments   0(0)  
Restricted cash and investments99    1
Receivables26292110  2
Inventory, net of allowances, customer advances and progress billings3332   
Inventory3332   
Prepaid expense1113     
Deferred rent asset00     
Other current assets302    
Other undisclosed current assets  1213785
Total current assets:146166203106236224149
Noncurrent Assets
Operating lease, right-of-use asset1619
Property, plant and equipment2344522
Intangible assets, net (including goodwill)74404448   
Intangible assets, net (excluding goodwill)74404448   
Restricted cash and investments344444 
Other undisclosed noncurrent assets223271011
Total noncurrent assets:98695659161613
TOTAL ASSETS:244235259166253240163
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities73886758373247
Accounts payable12192128201815
Accrued liabilities61694631171529
Employee-related liabilities      2
Debt143     
Other undisclosed current liabilities27     (2)
Total current liabilities:114916758373244
Noncurrent Liabilities
Long-term debt and lease obligation10423     
Long-term debt, excluding current maturities84      
Operating lease, liability2023
Liabilities, other than long-term debt0 65611
Deferred revenue and credits5611
Accounts payable and accrued liabilities0      
Deferred rent credit  6
Other undisclosed noncurrent liabilities3210415248   
Total noncurrent liabilities:13612715854611
Total liabilities:250217225112433446
Stockholders' equity
Stockholders' equity attributable to parent(6)173453210206117
Common stock0000000
Additional paid in capital1,3321,2951,2361,1421,006727399
Accumulated other comprehensive income (loss) 0(0) (0)(0)(0)
Accumulated deficit(1,338)(1,278)(1,202)(1,088)(797)(521)(281)
Receivable from shareholders or affiliates for issuance of capital stock   (0)  (1)
Total stockholders' equity:(6)173453210206117
TOTAL LIABILITIES AND EQUITY:244235259166253240163

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues22527225128   
Revenue, net28(3)(0) 
Cost of revenue
(Cost of Goods and Services Sold)
  (35)(6)   
Gross profit:22527221622   
Operating expenses(256)(311)(346)(320)(277)(240)(142)
Other undisclosed operating income  35630 
Operating loss:(30)(39)(95)(292)(277)(240)(142)
Nonoperating income (expense)(29)(36)(19)0110
Investment income, nonoperating0321110
Other nonoperating income (expense)00(1)(0)(0)0(0)
Interest and debt expense(14)(8)(0)(1)   
Loss from continuing operations before equity method investments, income taxes:(74)(84)(114)(293)(276)(239)(142)
Other undisclosed income from continuing operations before income taxes14      
Loss from continuing operations before income taxes:(60)(84)(114)(293)(276)(239)(142)
Income tax expense(0)(0)(0)    
Loss before gain (loss) on sale of properties:(60)(84)(114)(293)(276)(239)(142)
Other undisclosed net income 80    
Net loss:(60)(76)(114)(293)(276)(239)(142)
Other undisclosed net income attributable to parent   1   
Net loss available to common stockholders, diluted:(60)(76)(114)(292)(276)(239)(142)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(60)(76)(114)(293)(276)(239)(142)
Comprehensive loss:(60)(76)(114)(293)(276)(239)(142)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0(0)10(0)(0)
Comprehensive loss, net of tax, attributable to parent:(60)(76)(114)(292)(276)(239)(142)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: